98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/liv.70136 | DOI Listing |
World J Urol
September 2025
Sindh Medical College, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan.
J Allergy Clin Immunol Pract
September 2025
Associate Professor of Medicine, Medical Director of Clinical Asthma Research, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center. Electronic address:
Asthma and allergic diseases are heterogeneous conditions driven by complex immunological pathways, with type 2 (T2) inflammation being a key but not exclusive component. Advances in immunology have spurred interest in a breadth of mechanisms and innovative therapeutic strategies, including novel targets, extended dosing intervals, and combined-target therapies. This clinical commentary provides a critical overview of ongoing clinical trials and emerging evidence supporting the use of these therapies in asthma and other allergic conditions.
View Article and Find Full Text PDFInt J Surg
September 2025
Department of Urology, Qingdao Municipal Hospital, Qingdao, People's Republic of China.
BMJ Oncol
September 2025
Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
Contraception
September 2025
School of Nursing, The University of North Carolina at Chapel Hill. Electronic address:
Background: Chatbots are increasingly utilized in the healthcare landscape, including in sexual and reproductive health (SRH). These tools have shown significant potential in enhancing accessibility to health education and services, particularly with the addition of artificial intelligence. This commentary explores the utilization of chatbots for delivering SRH care, assessing their potential to impact health equity and access within rural and underserved settings and evaluating their effectiveness and safety.
View Article and Find Full Text PDF